Nu-Med Plus (NUMD) Income towards Parent Company (2012 - 2025)
Nu-Med Plus (NUMD) reported Income towards Parent Company of -$12618.0 for Q4 2025, down 19.55% on a YoY basis from -$15683.3 in Q4 2024, and down 5.45% sequentially from -$11966.0 in Q3 2025.
Nu-Med Plus (NUMD) Income towards Parent Company (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Income towards Parent Company data on file, last reported at -$12618.0 in Q4 2025.
- For the quarter ending Q4 2025, Income towards Parent Company fell 19.55% year-over-year to -$12618.0; the trailing twelve-month figure through Dec 2025 stood at -$56182.0 (up 17.8% YoY), and the FY2025 full-year result was -$56182.0, up 17.8% from the prior year.
- Income towards Parent Company retreated to -$12618.0 in Q4 2025, from -$11966.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $42606.0 in Q4 2022 to a low of -$2.2 million in Q4 2021.
- A 5-year average of -$164784.9 and a median of -$23073.0 in 2023 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company slumped 330.45% in 2021 and jumped 101.95% in 2022, its largest moves.
- Tracing NUMD's Income towards Parent Company over 5 years: stood at -$2.2 million in 2021, then jumped by 101.95% to $42606.0 in 2022, then slumped by 232.84% to -$56596.0 in 2023, then surged by 81.35% to -$10555.0 in 2024, then declined by 19.55% to -$12618.0 in 2025.
- Business Quant data shows NUMD's Income towards Parent Company at -$12618.0 in Q4 2025, -$11966.0 in Q3 2025, and -$11665.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,618.00 |
| Sep 30, 2025 | -11,966.00 |
| Jun 30, 2025 | -11,665.00 |
| Mar 31, 2025 | -19,933.00 |
| Dec 31, 2024 | -10,555.00 |
| Sep 30, 2024 | -18,677.00 |
| Jun 30, 2024 | -17,287.00 |
| Mar 31, 2024 | -21,826.00 |
| Dec 31, 2023 | -56,596.00 |
| Sep 30, 2023 | -16,406.00 |
| Jun 30, 2023 | -24,320.00 |
| Mar 31, 2023 | -28,204.00 |
| Dec 31, 2022 | 42,606.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -59,653.00 |
| Dec 31, 2021 | -2.19 Mn |
| Sep 30, 2021 | -118,366.00 |
| Jun 30, 2021 | -251,990.00 |
| Mar 31, 2021 | -356,748.00 |